EUCAN AIM Survey: Meet the Advisors
Jean Bousquet

Jean Bousquet, MD, PhD University Hospital Arnaud de Villeneuve Montpellier, France

Jean Bousquet is a Professor of Pulmonary Medicine at the University of Montpellier in France.

He received his MD and PhD in pharmacy in November of 1979, and trained in allergology and thoracic medicine at the Montpellier University Hospital.

For many years, Dr. Bousquet’s research was focused on Mediterranean allergens and allergen-specific immunotherapy. His focus was then directed toward asthma research, and he demonstrated the importance of the inflammatory component in the severity of asthma. He proposed the concept of airways remodeling in asthma and studied this process. Dr. Bousquet continued to examine the relationships between asthma and rhinitis as a comorbidity, particularly in severely-affected patients, and he now focuses on severe asthma.

For 13 years, Dr. Bousquet was Director of the INSERM Laboratory for the Immunopathology of Asthma and is also past chairman of the Global Initiative for Asthma (GINA).

He currently holds a teaching position in Allergy and Pulmonary Medicine at the Montpellier University.

Dr. Bousquet was the founder of ARIA (Allergic Rhinitis and its Impact on Asthma), in collaboration with the World Health Organization, and is currently Chairman.

He is also Chairman of the World Health Organization (WHO) Global Alliance against Chronic Respiratory Diseases (GARD), Director of the WHO Collaborating Centre for Asthma and Rhinitis in Montpellier, and Vice President of the European Union–funded network of excellence GA2LEN (Global Allergy and Asthma European Network).

Dr. Bousquet is a member of various international and national societies and has held the position of President of the Societé Française d’Allergologie et d’Immunologie Clinique.

Dr. Bousquet has edited and authored numerous publications, including 10 books and more than 525 peer-reviewed papers.

He served as editor of the European Respiratory Review from 1998 to 2002, and is presently serving as editor in chief of Allergy. He is or has been a member of the editorial board of the American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology, Clinical Experimental Allergy, Allergy Clinical Immunology International, Academy of Allergy and Clinical Immunology, International Archives of Allergy and Applied Immunology, and International Allergology.

Leonardo Fabbri

Leonardo Fabbri, MD University of Modena and Reggio Emilia Modena, Italy

Leonardo M. Fabbri is Professor of Respiratory Medicine; Director of the Section of Respiratory Diseases of the Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia. He received his doctorate in medicine and surgery at the University Padua in 1972; his board in occupational medicine, University Padua, in 1975 (70/70 summa cum laude); and his board of respiratory medicine, University Bologna, in 1978.

Dr. Fabbri was a Visiting Research Fellow, Department of Respiratory Diseases, Tulane University and at Cardiovascular Research Institute, University California, San Francisco. He served as chief editor for European Respiratory Review and the European Respiratory Monograph and as associate editor of the European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, and, from 2010, European Journal of Clinical Investigation. He was member of the Executive Committee of the Global Initiative on Asthma (GINA) (1990-2001); member of Scientific Committee of Global Initiative on Obstructive Lung Disease (GOLD) (1997-2005); Chairman of Scientific Committee, GOLD (2001-2004); member of Workshop Panel of GOLD (2001-2005); chairman of Executive Committee GOLD (2004-2005), and back again in the Scientific Committee from 2009 to the present.

He was elected vice-president of the European Respiratory Society (ERS) in 2005, with mandate to become President Elect (2006-2007), President (2007-2008), and Past President (2008-2009). He has published more than 260 papers in extenso in peer-reviewed journals.

Hirsh Index (August 2010): 66

David Price

David Price, MD University of Aberdeen Scotland, United Kingdom

David Price is the Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen, Scotland, and Affiliate Associate Professor in the Department of General Practice at the University of Adelaide in Australia. He is the ex-chair of the research committee of the International Primary Care Respiratory Group and is also a member of the executive committees for the international ARIA and EPOS guidelines groups. He is also director for the Comprehensive Local Research Network in Norfolk and Suffolk and an honorary consultant at the Norfolk and Norwich Hospital and NHS Norfolk.

He completed his medical degree at Cambridge University in 1984, and his General Practitioner training in Norwich in 1989 where he worked as a principal in practice until 2000. He now works in the Norfolk community-based respiratory and allergy service.

He is extensively involved in respiratory and allergy research. David Price’s special areas of interest are “real-life” effectiveness and cost effectiveness of interventions, clinical trial design, compliance, and patient attitudes toward their diseases. He has authored over 200 peer-reviewed publications since 2000 and is responsible for approximately $12 million in grants.

Malcolm Sears

Malcolm Sears, MB, ChB, FRACP, FRCPC, FAAAAI St. Joseph’s Healthcare Ontario, Canada

Dr. Malcolm Sears graduated from the University of Otago, Dunedin, New Zealand, and was on faculty there until 1990 when he was recruited as the Director of the Firestone Regional Chest and Allergy Unit (the forerunner of the Firestone Institute of Respiratory Health), Director of Respiratory Medicine at St. Joseph’s Healthcare and Professor in the Department of Medicine at McMaster University. In 2002, he stepped down as Clinical Director and became Research Director of the Firestone Institute until 2009.

Dr. Sears is involved in many studies investigating the epidemiology and natural history of asthma with particular focus on its frequency, risk factors, and characteristics in large populations. Of note is an important longitudinal study that he has been conducting for more than 30 years, studying the incidence and impact of asthma in a birth cohort of New Zealand children followed from infancy to adulthood. Other research includes assessment of asthma therapies, and the effects of indoor allergens, viral infections, air pollutants, smoking, and hormones in respiratory disease. He is an investigator in the AllerGen Network of Centers of Excellence, and is directing a new birth cohort study in Canada funded by CIHR and Allergen.

Dr. Sears has published over 200 peer-reviewed papers and book chapters, as well as numerous abstracts. He lectures frequently at national and international scientific meetings and serves on many asthma advisory boards.

Ulrich Wahn

Ulrich Wahn, MD Berlin Children’s Hospital Charité, Virchow-Klinikum Berlin, Germany

Ulrich Wahn, MD, is a Professor of Pediatrics and Allergy at the Clinic of Pediatric Pulmonology and Immunology, Berlin Children's Hospital Charité, Virchow-Klinikum, Berlin, Germany. In the year from 1971 until 1972 professor Wahn was junior house officer at the University clinic, in Heidelberg. In 1972, he became academic employee at the German cancer research centre, in Heidelberg. In the following five years, he was academic employee at the pediatric University clinic, in Heidelberg. In 1977, he became medical specialist for pediatrics. Furthermore he acquired additional denomination in allergology, in 1978. Professor Wahn was scholarship holder of the DFG at the National Institutes of Health (Clinical immunology Section) in Bethesda, USA. From 1981 until 1985, he was senior physician at the pediatric University clinic, in Bochum, as well as assistant professor at the Ruhr University, Bochum. Since 1986, he is professor for pediatric pneumology and immunology (C3) at the pediatric University clinic of the free University Berlin, and at the same time Chief physician of the child department at the HELIOS Hospital Emil von Behring.

Since 1998, professor Wahn is director of the clinic for pediatrics with a major in pneumology and immunology (C4) at the Charité, campus Virchow-clinics. Moreover he served as president of the European Academy of Allergy and clinical Immunology, from 2003 to 2005.

Professor Wahn has publicated 400 original works, 11 academic books from different fields of pediatrics, in specific pneumology, allergology and immunology. He was president of a variety of National and International Congresses and has recently been appointed chief editor of the journal Pediatric Allergy and Immunology.

Joaquin Sastre Domínguez

Joaquin Sastre Domínguez, PhD Fundacio Jimenez Diaz Allergy Service Madrid, Spain

Joaquin Sastre Domínguez is an allergy specialist and professor at Fundacio Jimenez Diaz Allergy Service in Madrid, Spain. He obtained his bachelor of medicine and surgery at the Autonomous University of Madrid in 1979, and his PhD from the same university in 1985. Dr. Sastre’s research interests include food-induced asthma, pathogenesis of occupational asthma, and application of gene therapy in asthma.

Dr. Sastre has 171 publications in selected journals and has authored chapters in 20 books. He holds membership on the Executive Committee of the International Academy of Allergy and Immunology World Allergy Organization, Spanish Society of Pathology, Spanish Society of Immunology, European Academy of Allergology and Clinical Immunology, and the European Respiratory Society; and is a fellow of the American Thoracic Society and the American Academy of Allergy and Clinical Immunology.

The 2010 EUCAN AIM Survey is one of the largest, most comprehensive patient surveys ever conducted in Europe & Canada on the multidimensional aspects of asthma knowledge, management, and treatment.

The EUCAN AIM Survey was conducted by Abt SRBI Inc. and sponsored by MSD. Results are based on preliminary findings and may vary from those listed in the final executive summary of the EUCAN AIM Survey.